- Home
- APLT vs NIU Comparison
APLT vs NIU Comparison
Compare APLT & NIU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLT
- NIU
- Stock Information
- Founded
- APLT 2016
- NIU 2014
- Country
- APLT United States
- NIU China
- Employees
- APLT N/A
- NIU N/A
- Industry
- APLT Biotechnology: Pharmaceutical Preparations
- NIU Auto Manufacturing
- Sector
- APLT Health Care
- NIU Consumer Discretionary
- Exchange
- APLT Nasdaq
- NIU Nasdaq
- Market Cap
- APLT 140.8M
- NIU 141.2M
- IPO Year
- APLT 2019
- NIU 2018
- Fundamental
- Price
- APLT $1.10
- NIU $1.80
- Analyst Decision
- APLT Buy
- NIU
- Analyst Count
- APLT 6
- NIU 0
- Target Price
- APLT $6.60
- NIU N/A
- AVG Volume (30 Days)
- APLT 10.8M
- NIU 466.5K
- Earning Date
- APLT 11-07-2024
- NIU 11-18-2024
- Dividend Yield
- APLT N/A
- NIU N/A
- EPS Growth
- APLT N/A
- NIU N/A
- EPS
- APLT N/A
- NIU N/A
- Revenue
- APLT N/A
- NIU $420,244,416.00
- Revenue This Year
- APLT N/A
- NIU $16.60
- Revenue Next Year
- APLT $5,117.00
- NIU $24.42
- P/E Ratio
- APLT N/A
- NIU N/A
- Revenue Growth
- APLT N/A
- NIU 5.83
- 52 Week Low
- APLT $1.03
- NIU $1.57
- 52 Week High
- APLT $10.62
- NIU $3.50
- Technical
- Relative Strength Index (RSI)
- APLT 17.64
- NIU 40.90
- Support Level
- APLT $1.03
- NIU $1.78
- Resistance Level
- APLT $1.37
- NIU $2.14
- Average True Range (ATR)
- APLT 0.33
- NIU 0.09
- MACD
- APLT -0.15
- NIU 0.01
- Stochastic Oscillator
- APLT 0.75
- NIU 10.53
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
About NIU Niu Technologies
Niu Technologies designs, manufactures and sells high-performance electric motorcycles, scooters, bicycles, and kick-scooters. The company has a product portfolio consisting of electric motorcycle, moped and bicycle series, including the NQi, MQi, UQi, F series, and others, and micro-mobility series, including the kick-scooter series KQi and the e-bike series BQi. The company's principal operations and geographic markets are predominantly in the People's Republic of China. It also generates revenue from Europe and other regions.